162 related articles for article (PubMed ID: 28802580)
1. Suppressive role of OGT-mediated O-GlcNAcylation of BAP1 in retinoic acid signaling.
Moon S; Lee YK; Lee SW; Um SJ
Biochem Biophys Res Commun; 2017 Oct; 492(1):89-95. PubMed ID: 28802580
[TBL] [Abstract][Full Text] [Related]
2. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.
Konrad RJ; Zhang F; Hale JE; Knierman MD; Becker GW; Kudlow JE
Biochem Biophys Res Commun; 2002 Apr; 293(1):207-12. PubMed ID: 12054585
[TBL] [Abstract][Full Text] [Related]
3. Modulation of O-GlcNAcylation Regulates Autophagy in Cortical Astrocytes.
Rahman MA; Hwang H; Cho Y; Rhim H
Oxid Med Cell Longev; 2019; 2019():6279313. PubMed ID: 31827688
[TBL] [Abstract][Full Text] [Related]
4. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
5. Conditions Inducing Excessive O-GlcNAcylation Inhibit BMP2-Induced Osteogenic Differentiation of C2C12 Cells.
Gu H; Song M; Boonanantanasarn K; Baek K; Woo KM; Ryoo HM; Baek JH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315243
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.
Lee SW; Youn H; Kim EJ; Um SJ
Mol Cell; 2013 Jul; 51(2):200-10. PubMed ID: 23850490
[TBL] [Abstract][Full Text] [Related]
7. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
[TBL] [Abstract][Full Text] [Related]
8. The effects of O-GlcNAc alteration on Alzheimer-like neurodegeneration in SK-N-SH cells.
Ding N; Peng P; Chu YJ; Wang JJ; Chen SY; Arulthas R; Deng YQ
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):243-248. PubMed ID: 30181664
[TBL] [Abstract][Full Text] [Related]
9. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
11.
Zhang Z; Parker MP; Graw S; Novikova LV; Fedosyuk H; Fontes JD; Koestler DC; Peterson KR; Slawson C
J Biol Chem; 2019 Jan; 294(4):1363-1379. PubMed ID: 30523150
[TBL] [Abstract][Full Text] [Related]
12. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc transferase affects the signal transduction of β1 adrenoceptor in adult rat cardiomyocytes by increasing the O-GlcNAcylation of β1 adrenoceptor.
Cao H; Hu Y; Zhu X; Yao N; Gu J; Wang Y; Zhu W
Biochem Biophys Res Commun; 2020 Jul; 528(1):71-77. PubMed ID: 32471715
[TBL] [Abstract][Full Text] [Related]
14. OGT upregulates myogenic IL-6 by mediating O-GlcNAcylation of p65 in mouse skeletal muscle under cold exposure.
Hu Y; Liu Y; Yang Y; Lv H; Lian S; Xu B; Li S
J Cell Physiol; 2022 Feb; 237(2):1341-1352. PubMed ID: 34668190
[TBL] [Abstract][Full Text] [Related]
15. Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells.
Shi FT; Kim H; Lu W; He Q; Liu D; Goodell MA; Wan M; Songyang Z
J Biol Chem; 2013 Jul; 288(29):20776-20784. PubMed ID: 23729667
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
Xu C; Liu G; Liu X; Wang F
Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
[TBL] [Abstract][Full Text] [Related]
17. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
18. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
20. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
